Investor Area

ActionGrid is a Enterprise AI company building the definitive patient relationship layer for the healthcare industry. We are not just another HealthTech app; we are a strategic platform provider that empowers large healthcare organizations to build deeper, more effective relationships with their patients through our proprietary AI technology.

Dr. Guido addresses the critical moment of uncertainty and anxiety a patient experiences when faced with a health concern. Before a patient even reaches a doctor, they are often confused by symptoms or complex medical reports. Our AI Doctor, Dr. Guido, provides empathetic, multi-language, first-line assistance, transforming patient anxiety into empowerment and enabling more informed and efficient consultations with human medical professionals.

We have two core, synergistic products:

• The ActionGrid Platform: Our flagship Enterprise SaaS product sold to enterprise clients. It is a powerful backend platform that leverages sophisticated AI agents to manage patient interactions, analyze data, and provide valuable insights to healthcare providers.

• The Dr. Guido Mobile App: Our strategic Consumer Mobile App asset. While free to users, this app is the engine of our data and go-to-market strategy. It captures unique interaction data that fuels our AI models and generates a pipeline of organic, bottom-up leads for our enterprise platform.

Our business model is 100% Enterprise SaaS. We generate revenue through recurring subscriptions to the ActionGrid platform from high-value clients, including hospital groups, insurance companies, and pharmaceutical firms. The Dr. Guido app is a strategic investment in R&D and marketing, designed to lower our Customer Acquisition Cost (CAC) and build a defensible technological moat, directly fueling the growth of our profitable Enterprise engine.

Our competitive advantage is built on a unique, multi-layered strategy that is difficult to replicate:

• Strategic Focus: While competitors focus on diagnostics, we are positioned to own the "relationship layer," a more valuable and strategic space in the patient journey.

• The Data Moat: Our hybrid model allows us to build a proprietary Data Cloud from unique patient interactions. This data is a core asset that makes our AI platform progressively smarter, a virtuous cycle that pure Enterprise players cannot replicate.

• Capital-Efficient GTM: The Dr. Guido app acts as a powerful lead-generation tool, creating bottom-up demand within large organizations and significantly reducing the CAC for our high-value enterprise contracts.

Our Ideal Customer Profile (ICP) consists of mid-to-large-sized enterprises seeking to innovate their patient engagement models. This includes:

• Industries: Healthcare Providers, Health Insurance, and Pharmaceuticals.

• Customer Types: Private hospital groups, innovative health insurance providers, and pharmaceutical companies with patient support programs.

• Key Titles: Chief Innovation Officer, Chief Medical Officer, Head of Digital Transformation, and Director of Patient Experience.

We have achieved significant validation across both product and market:

• Product Validation: The Dr. Guido app is live globally, demonstrating strong organic traction and validating a core user need, particularly for our multi-language capabilities.

• Go-to-Market Validation: This organic traction de-risks our enterprise sales strategy. It serves as a powerful proof point and has already helped us build a qualified pipeline of over 700 enterprise leads in our initial market.

Our team is a potent blend of seasoned leadership and elite technical talent. It is led by founders with deep expertise in data-driven digital marketing, Enterprise commercialization, and AI product development.

This experienced core is complemented by top-tier AI architects and engineers from Europe's leading universities. We have the right balance of vision and execution capability to dominate this market.

Yes. Our intellectual property extends beyond traditional patents. Our core IP is our proprietary AI orchestration platform and, most critically, the unique, ever-growing dataset generated by the Dr. Guido app.

This "Data Moat" is a highly defensible and appreciating asset that constitutes the foundation of our long-term competitive advantage.

This is a cornerstone of our strategy and a key use of funds. The current AI healthcare landscape is an evolving regulatory frontier. We see this not as a barrier, but as an opportunity to build a powerful regulatory moat.

Our strategy is to proactively pursue the highest standards of compliance to build trust and defensibility.

A primary allocation of our pre-seed capital is dedicated to achieving critical certifications, including GDPR, the EU AI Act, and Medical Device Regulation (MDR).

Attaining these certifications will not only be a compliance milestone but a core product differentiator, making our platform exceptionally difficult for competitors to replicate and positioning ActionGrid as the trusted leader in the market.